Literature DB >> 2559886

Better survival in women than in men after radical resection of hepatocellular carcinoma.

N Nagasue1, G Galizia, H Yukaya, H Kohno, Y C Chang, T Hayashi, T Nakamura.   

Abstract

During the period between January 1980 and December 1987, 229 male and 39 female adult patients with primary hepatocellular carcinoma (HCC) were hospitalized in our unit. Radical hepatic resection was carried out in 90 (39.3%) males and 17 (43.6%) females in whom no specific cancer treatment had been attempted preoperatively. The 1-, 3-, and 5-year survival rates in the male and female patients were 78% and 70%, 45% and 52%, and 19% and 52%, respectively. The difference was significant after 47 months. No substantial differences were found between the two groups with respect to age, preoperative clinical condition and laboratory data, method of liver resection, postoperative morbidity and mortality, postoperative adjuvant chemotherapy, and histopathology of HCC and the liver. Only the incidence of alcohol abuse was significantly different, being higher in male than in female patients. However, the survival analysis demonstrated that alcohol abuse had had no influence on recurrence rate and long-term survival in either male or female patients. As a control, survival was analyzed for the patients with similar clinicopathological background but without HCC who had undergone distal splenorenal shunt for esophageal varices. There was no significant difference between the male and female patients. The current clinical results seems to support our hypothesis based upon sex hormone receptor studies that HCC may be androgen-dependent.

Entities:  

Mesh:

Year:  1989        PMID: 2559886

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Shao-Bin Cheng; Tse-Jia Liu; Fang-Ku P'eng
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

2.  Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Authors:  Zhuona Rong; Tingting Fan; Huiling Li; Juan Li; Kangwei Wang; Xinxin Wang; Jianyi Dong; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Mol Cell Proteomics       Date:  2017-05-16       Impact factor: 5.911

3.  Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.

Authors:  Pisit Tangkijvanich; Varocha Mahachai; Pongspeera Suwangool; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

4.  Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood.

Authors:  L Zachau; C Zeckey; J Schlue; J Sander; C Meyer-Heithuis; M Winkler; J Klempnauer; H Schrem
Journal:  World J Surg Oncol       Date:  2012-05-30       Impact factor: 2.754

5.  Gender and ploidy in cancer survival.

Authors:  Susanne Schulze; Iver Petersen
Journal:  Cell Oncol (Dordr)       Date:  2011-03-22       Impact factor: 6.730

6.  Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.

Authors:  Nicole E Rich; Caitlin C Murphy; Adam C Yopp; Jasmin Tiro; Jorge A Marrero; Amit G Singal
Journal:  Aliment Pharmacol Ther       Date:  2020-06-29       Impact factor: 9.524

7.  Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma.

Authors:  P H Yin; H C Lee; G Y Chau; Y T Wu; S H Li; W Y Lui; Y H Wei; T Y Liu; C W Chi
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.